HOE-140, an Antagonist of B2 Receptor, Protects Against Memory Deficits and Brain Damage Induced by Moderate Lateral Fluid Percussion Injury in Mice

Rationale: There are evidences indicating the role of kinins in pathophysiology of traumatic brain injury, but little is known about their action on memory deficits.

Objectives: Our aim was to establish the role of bradykinin receptors B₁ (B₁R) and B₂ (B₂R) on the behavioral, biochemical, and histologic features elicited by moderate lateral fluid percussion injury (mLFPI) in mice.

Methods: The role of kinin B₁ and B₂ receptors in brain damage, neuromotor, and cognitive deficits induced by mLFPI, was evaluated by means of subcutaneous injection of B₂R antagonist (HOE-140; 1 or 10 nmol/kg) or B₁R antagonist (des-Arg9-[Leu8]-bradykinin (DAL-Bk; 1 or 10 nmol/kg) 30 min and 24 h after brain injury. Brain damage was evaluated in the cortex, being considered as lesion volume, inflammatory, and oxidative damage. The open field and elevated plus maze tests were performed to exclude the nonspecific effects on object recognition memory test.

Results: Our data revealed that HOE-140 (10 nmol/kg) protected against memory impairment. This treatment attenuated the brain edema, interleukin-1β, tumor necrosis factor-α, and nitric oxide metabolites content elicited by mLFPI. Accordingly, HOE-140 administration protected against the increase of nicotinamide adenine dinucleotide phosphate oxidase activity, thiobarbituric-acid-reactive species, protein carbonylation generation, and Na⁺ K⁺ ATPase inhibition induced by trauma. Histologic analysis showed that HOE-140 reduced lesion volume when analyzed 7 days after brain injury.

Conclusions: This study suggests the involvement of the B₂ receptor in memory deficits and brain damage caused by mLFPI in mice.

Citing Articles

Bioinformatics integration reveals key genes associated with mitophagy in myocardial ischemia-reperfusion injury.

Chen Z, Liu T, Yuan H, Sun H, Liu S, Zhang S BMC Cardiovasc Disord. 2024; 24(1):183.

PMID: 38539069 PMC: 10967080. DOI: 10.1186/s12872-024-03834-x.

Combined network pharmacology and virtual reverse pharmacology approaches for identification of potential targets to treat vascular dementia.

Lagunin A, Ivanov S, Gloriozova T, Pogodin P, Filimonov D, Kumar S Sci Rep. 2020; 10(1):257.

PMID: 31937840 PMC: 6959222. DOI: 10.1038/s41598-019-57199-9.

A Single Primary Blast-Induced Traumatic Brain Injury in a Rodent Model Causes Cell-Type Dependent Increase in Nicotinamide Adenine Dinucleotide Phosphate Oxidase Isoforms in Vulnerable Brain Regions.

Rao K, Iring S, Younger D, Kuriakose M, Skotak M, Alay E J Neurotrauma. 2018; 35(17):2077-2090.

PMID: 29648986 PMC: 6098412. DOI: 10.1089/neu.2017.5358.

Implantation of Neuronal Stem Cells Enhances Object Recognition without Increasing Neurogenesis after Lateral Fluid Percussion Injury in Mice.

Ngwenya L, Mazumder S, Porter Z, Minnema A, Oswald D, Farhadi H Stem Cells Int. 2018; 2018:4209821.

PMID: 29531536 PMC: 5818962. DOI: 10.1155/2018/4209821.

Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.

Nokkari A, Abou-El-Hassan H, Mechref Y, Mondello S, Kindy M, Jaffa A Prog Neurobiol. 2018; 165-167:26-50.

PMID: 29355711 PMC: 6026079. DOI: 10.1016/j.pneurobio.2018.01.003.

References

Chao J, Woodley C, Chao L, Margolius H . Identification of tissue kallikrein in brain and in the cell-free translation product encoded by brain mRNA. J Biol Chem. 1983; 258(24):15173-8. View

Baratz R, Tweedie D, Rubovitch V, Luo W, Yoon J, Hoffer B . Tumor necrosis factor-α synthesis inhibitor, 3,6'-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice. J Neurochem. 2011; 118(6):1032-42. PMC: 3397686. DOI: 10.1111/j.1471-4159.2011.07377.x. View

Ayer R, Jadhav V, Sugawara T, Zhang J . The neuroprotective effects of cyclooxygenase-2 inhibition in a mouse model of aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl. 2011; 111:145-9. DOI: 10.1007/978-3-7091-0693-8_24. View

Levine R, Garland D, Oliver C, Amici A, Climent I, Lenz A . Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990; 186:464-78. DOI: 10.1016/0076-6879(90)86141-h. View

Kaplanski J, Asa I, Artru A, Azez A, Ivashkova Y, Rudich Z . LF 16-0687 Ms, a new bradykinin B2 receptor antagonist, decreases ex vivo brain tissue prostaglandin E2 synthesis after closed head trauma in rats. Resuscitation. 2003; 56(2):207-13. DOI: 10.1016/s0300-9572(02)00371-4. View

Hellal F, Pruneau D, Palmier B, Faye P, Croci N, Plotkine M . Detrimental role of bradykinin B2 receptor in a murine model of diffuse brain injury. J Neurotrauma. 2003; 20(9):841-51. DOI: 10.1089/089771503322385773. View

Wada K, Chatzipanteli K, Busto R, Dietrich W . Role of nitric oxide in traumatic brain injury in the rat. J Neurosurg. 1998; 89(5):807-18. DOI: 10.3171/jns.1998.89.5.0807. View

Kaplanski J, Pruneau D, Asa I, Artru A, Azez A, Ivashkova Y . LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces brain edema and improves long-term neurological function recovery after closed head trauma in rats. J Neurotrauma. 2002; 19(8):953-64. DOI: 10.1089/089771502320317104. View

Lee Y, Zachrisson O, Tonge D, McNaughton P . Upregulation of bradykinin B2 receptor expression by neurotrophic factors and nerve injury in mouse sensory neurons. Mol Cell Neurosci. 2002; 19(2):186-200. DOI: 10.1006/mcne.2001.1073. View

10.

Ziebell J, Bye N, Semple B, Kossmann T, Morganti-Kossmann M . Attenuated neurological deficit, cell death and lesion volume in Fas-mutant mice is associated with altered neuroinflammation following traumatic brain injury. Brain Res. 2011; 1414:94-105. DOI: 10.1016/j.brainres.2011.07.056. View

11.

Bay E, Covassin T . Chronic stress, somatic and depressive symptoms following mild to moderate traumatic brain injury. Arch Psychiatr Nurs. 2012; 26(6):477-86. DOI: 10.1016/j.apnu.2012.06.002. View

12.

Ates O, Cayli S, Altinoz E, Gurses I, Yucel N, Sener M . Neuroprotection by resveratrol against traumatic brain injury in rats. Mol Cell Biochem. 2006; 294(1-2):137-44. DOI: 10.1007/s11010-006-9253-0. View

13.

Hsieh H, Wang H, Wu C, Yang C . Reactive Oxygen Species-Dependent c-Fos/Activator Protein 1 Induction Upregulates Heme Oxygenase-1 Expression by Bradykinin in Brain Astrocytes. Antioxid Redox Signal. 2010; 13(12):1829-44. DOI: 10.1089/ars.2009.2957. View

14.

Albert-Weissenberger C, Stetter C, Meuth S, Gobel K, Bader M, Siren A . Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation. J Cereb Blood Flow Metab. 2012; 32(9):1747-56. PMC: 3434625. DOI: 10.1038/jcbfm.2012.62. View

15.

Raslan F, Schwarz T, Meuth S, Austinat M, Bader M, Renne T . Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation. J Cereb Blood Flow Metab. 2010; 30(8):1477-86. PMC: 2949241. DOI: 10.1038/jcbfm.2010.28. View

16.

Noda M, Kariura Y, Pannasch U, Nishikawa K, Wang L, Seike T . Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J Neurochem. 2007; 101(2):397-410. DOI: 10.1111/j.1471-4159.2006.04339.x. View

17.

Zhan H, Tada T, Nakazato F, Tanaka Y, Hongo K . Spatial learning transiently disturbed by intraventricular administration of ouabain. Neurol Res. 2004; 26(1):35-40. DOI: 10.1179/016164104773026507. View

18.

Schneider Oliveira M, Flavia Furian A, Freire Royes L, Rechia Fighera M, de Carvalho Myskiw J, Gindri Fiorenza N . Ascorbate modulates pentylenetetrazol-induced convulsions biphasically. Neuroscience. 2004; 128(4):721-8. DOI: 10.1016/j.neuroscience.2004.07.012. View

19.

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

20.

Gilgun-Sherki Y, Rosenbaum Z, Melamed E, Offen D . Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev. 2002; 54(2):271-84. DOI: 10.1124/pr.54.2.271. View